NCIt synonyms : Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain),
Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer;
NCIt definition : A monoclonal antibody directed against B7H1 (B7 homolog 1; programmed cell death ligand
1) with potential immunostimulating activity. Upon intravenous administration, durvalumab
binds to the cell surface antigen B7H1, thereby blocking B7H1 signaling. This may
activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against
B7H1-expressing tumor cells. B7H1, a member of the B7 protein superfamily and a negative
regulator of cytokine synthesis, is overexpressed on certain tumor cell types.;
https://www.has-sante.fr/jcms/p_3506840/fr/imfinzi-durvalumab-cancer-bronchique-non-a-petites-cellules 2024 false false false France evaluation of the transparency committee Imfinzi Durvalumab durvalumab durvalumab
--- https://pgtmsite.files.wordpress.com/2024/01/re_durvalumab_strategie-posologique_final4.pdf 2021 Canada drug information albumin/globulin ratio What Month is it Ratio durvalumab Strategy Regulatory Report durvalumab research report Durvalumab